Page 19 - BH-2-2
P. 19

Brain & Heart                                                      Oxidative stress and neurological disorders



               perspective. Neurochem Res. 2022;47(7):1853-1864.     doi: 10.1016/j.biopha.2020.110373
               doi: 10.1007/s11064-022-03598-w                 32.  Johnson JA, Johnson DA, Kraft AD,  et al. The Nrf2-ARE
                                                                  pathway: An indicator and modulator of oxidative stress in
            22.  Singh S, Chauhan K. Pharmacological approach using   neurodegeneration. Ann N Y Acad Sci. 2008;1147:61-69.
               doxycycline and tocopherol in rotenone induced oxidative
               stress, neuroinflammation and Parkinson’s like symptoms.      doi: 10.1196/annals.1427.036
               Int J Neurosci. 2022; 132:1-6.                  33.  Nguyen L, Lucke-Wold BP, Mookerjee SA,  et al. Role
               doi: 10.1080/00207454.2022.2154670                 of sigma-1 receptors in neurodegenerative diseases.
                                                                  J Pharmacol Sci. 2015;127(1):17-29.
            23.  Ahmed S, Hasan MM, Heydari M,  et al. Therapeutic
               potentials of crocin in medication of neurological disorders.      doi: 10.1016/j.jphs.2014.12.005
               Food Chem Toxicol. 2020;145:111739.             34.  Piechal A, Jakimiuk A, Mirowska-Guzel D. Sigma receptors and
               doi: 10.1016/j.fct.2020.111739                     neurological disorders. Pharmacol Rep. 2021;73(6):1582-1594.
            24.  Zhou DD, Luo M, Huang SY, et al. Effects and mechanisms      doi: 10.1007/s43440-021-00310-7
               of resveratrol on aging and age-related diseases. Oxid Med   35.  Ren P, Wang J, Li N, et al. Sigma-1 receptors in depression:
               Cell Longev. 2021;2021:9932218.                    Mechanism and therapeutic development. Front Pharmacol.
               doi: 10.1155/2021/9932218                          2022;13:925879.
            25.  Sebastiani G, Almeida-Toledano L, Serra-Delgado M,      doi: 10.3389/fphar.2022.925879
               et al. Therapeutic effects of catechins in less common   36.  Jia J, Cheng J, Wang C, Zhen X. Sigma-1 receptor-modulated
               neurological and neurodegenerative disorders.  Nutrients.   neuroinflammation in neurological diseases.  Front Cell
               2021;13(7):2232.                                   Neurosci. 2018;12:314.
               doi: 10.3390/nu13072232                            doi: 10.3389/fncel.2018.00314
            26.  Rahman MH, Akter R, Kamal MA. Prospective function   37.  Smith SB. Introduction to sigma receptors: Their role
               of different antioxidant containing natural products in the   in disease and as therapeutic targets.  Adv Exp Med Biol.
               treatment of neurodegenerative diseases. CNS Neurol Disord   2017;964:1-4.
               Drug Targets. 2021;20(8):694-703.
                                                                  doi: 10.1007/978-3-319-50174-1_1
               doi: 10.2174/1871527319666200722153611
                                                               38.  Zhang G, Li Q, Tao W,  et al. Sigma-1 receptor-regulated
            27.  Rauchová H. Coenzyme Q10 effects in neurological diseases.   efferocytosis by infiltrating circulating macrophages/
               Physiol Res. 2021;70(Suppl 4):S683-S714.           microglial cells protects against neuronal impairments and
                                                                  promotes functional recovery in cerebral ischemic stroke.
               doi: 10.33549/physiolres.934712
                                                                  Theranostics. 2023;13(2):543-559.
            28.  Mor A, Tankiewicz-Kwedlo A, Krupa A, Pawlak D.      doi: 10.7150/thno.77088
               Role of Kynurenine pathway in oxidative stress during
               neurodegenerative disorders. Cells. 2021;10(7):1603.  39.  Liguori I, Russo G, Curcio F, et al. Oxidative stress, aging,
                                                                  and diseases. Clin Interv Aging. 2018;13:757-772.
               doi: 10.3390/cells10071603
                                                                  doi: 10.2147/CIA.S158513
            29.  Eskandari MR, Eftekhari P, Abbaszadeh S, Noubarani  M,
               Shafaghi  B,  Pourahmad  J.  Inhibition  of  different  pain   40.  López-Otín C, Blasco MA, Partridge L, Serrano M,
               pathways attenuates oxidative stress in glial cells:   Kroemer  G. Hallmarks of aging: An expanding universe.
               A mechanistic view on neuroprotective effects of different   Cell. 2023;186(2):243-278.
               types of analgesics. Iran J Pharm Res. 2021;20(3):204-215.     doi: 10.1016/j.cell.2022.11.001
               doi: 10.22037/ijpr.2021.114476.14871            41.  Zhang H, Davies KJA, Forman HJ. Oxidative stress response
            30.  Moraes CA, Zaverucha-do-Valle C, Fleurance R,    and Nrf2 signaling in aging. Free Radic Biol Med. 2015;88(Pt
               Sharshar   T, Bozza FA, d’Avila JC. Neuroinflammation   B):314-336.
               in  sepsis:  Molecular  pathways  of microglia  activation.      doi: 10.1016/j.freeradbiomed.2015.05.036
               Pharmaceuticals (Basel). 2021;14(5):416.
                                                               42.  Pérez-Torres I, Castrejón-Téllez V, Soto ME, Rubio-
               doi: 10.3390/ph14050416                            Ruiz    ME,  Manzano-Pech  L,  Guarner-Lans  V.  Oxidative
            31.  Sharma V, Kaur A, Singh TG. Counteracting role of nuclear   stress, plant natural antioxidants, and obesity. Int J Mol Sci.
               factor erythroid 2-related factor 2 pathway in Alzheimer’s   2021;22(4):1786.
               disease. Biomed Pharmacother. 2020;129:110373.     doi: 10.3390/ijms22041786



            Volume 2 Issue 2 (2024)                         13                               doi: 10.36922/bh.2704
   14   15   16   17   18   19   20   21   22   23   24